AmM FORTITUDE Bioresorbable Drug-Eluting Coronary Scaffold

DEVICE2 trials

Sponsors

Amaranth Medical Inc.

Conditions

Coronary Artery DiseaseMyocardial Ischemia

Phase 2

Feasibility Study of the Amaranth Medical FORTITUDE Bioresorbable Drug-Eluting Coronary Stent

Amaranth Medical Inc.Coronary Artery Disease, Myocardial Ischemia

Start: 2014-09-30End: 2020-11-30Updated: 2016-06-08

Safety and Efficacy Study of the Amaranth Medical FORTITUDE Bioresorbable Drug-Eluting Coronary Stent

Amaranth Medical Inc.Coronary Artery Disease, Myocardial Ischemia

Start: 2015-02-28End: 2020-11-30Updated: 2016-06-08